Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...

Treating obstructive sleep apnea in people living with HIV reduces fatigue and improves cardiovascular health, with similar ...

Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

Patients with HIV experienced more delayed, interrupted, and less robust sleep and rest-activity rhythms compared with those ...

As HIV diagnoses continue increasing in metro Atlanta, the number of dollars for research and treatment is going down.

Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Infectious disease experts have hailed a move that will see a highly effective HIV prevention drug be sold at just 40 dollars ...

Dr. Brandon Hill, CEO of Vivent Health and a researcher in HIV and sexual issues, talks about changes in government funding.

Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously ...